Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00796796 · ClinicalTrials.gov registry record · Phase 1
Temsirolimus and Radiation for Non-Small Cell Lung Cancer
A Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00796796 is a Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 10 participants.
The verdict
NCT00796796, a Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
To determine the maximum tolerated dose of the drug temsirolimus given with radiation therapy for patients with non-small cell lung cancer.
Interventions
- RADIATION Radiation therapy
- DRUG Temsirolimus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-03 |
| Est. Completion | 2011-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00796796
The ClinicalTrials.gov registry entry for NCT00796796 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Radiation therapy is the first listed.
NCT00796796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00796796 about?
NCT00796796 is a clinical study titled "Temsirolimus and Radiation for Non-Small Cell Lung Cancer". To determine the maximum tolerated dose of the drug temsirolimus given with radiation therapy for patients with non-small cell lung cancer.
What is the current status of trial NCT00796796?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2009-03. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00796796?
The interventions under investigation include: Radiation therapy (RADIATION), Temsirolimus (DRUG).
Who is sponsoring clinical trial NCT00796796?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.